Breaking News Instant updates and real-time market news.

RARE

Ultragenyx

$84.19

2.52 (3.09%)

08:33
11/30/16
11/30
08:33
11/30/16
08:33

Ultragenyx announces 'positive' data from UX007 Phase 2 study

Ultragenyx Pharmaceutical announced positive 78-week data from the Phase 2 study of UX007 in patients with long-chain fatty acid oxidation disorder, or LC-FAOD. The frequency and duration of major medical events were reduced significantly during treatment with UX007, and patients demonstrated improved exercise tolerance and quality of life during the study. "The reduction in frequency and duration of hospitalizations and other major medical events suggests a clinically meaningful improvement for patients and is consistent with the data from the prior retrospective compassionate use study," said Emil D. Kakkis, M.D., Ph.D., Chief Executive Officer and President of Ultragenyx. "These results are encouraging and we continue to further develop the Phase 3 study design and endpoints before meeting with regulators and initiating the study in 2017."

RARE Ultragenyx
$84.19

2.52 (3.09%)

10/18/16
JEFF
10/18/16
NO CHANGE
JEFF
Jefferies sees 'attractive buying opportunities' in Biotech
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. While volatility will likely continue into the election, valuation multiples are near-historic lows and policy concerns, while valid, are likely overstated, the analysts tell investors in a research note. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment. Jefferies likes Gilead (GILD) and Celgene (CELG) among large-caps, The Medicines Co. (MDCO), Alkermes (ALKS) and Vertex (VRTX) among mid-caps, and Alder Biopharmaceuticals (ALDR), Cempra (CEMP), Ultragenyx (RARE) and Immunomedics (IMMU) among small-caps.
11/01/16
PIPR
11/01/16
NO CHANGE
Target $82
PIPR
Overweight
Ultragenyx risk/reward favorable after pullback, says Piper Jaffray
Piper Jaffray analyst Steven Breazzano says Ultragenyx's risk/reward profile is favorable following the recent pullback in the shares. The analyst recommends buying the stock based on the blockbuster potential of KRN23 in adult and pediatric X-linked hypophosphatemia patients. After taking a closer look at Ultragenyx's UX007 Phase 2 program for both fatty acid oxidation disorders and Glut1 deficiency syndrome, the analyst sees a greater than 50% chance of success in both. He notes the program would represent "meaningful upside" to his model. He reiterates an Overweight rating on Ultragenyx with an $82 price target.
11/08/16
ADAM
11/08/16
NO CHANGE
Target $108
ADAM
Buy
Ultragenyx price target lowered to $108 from $120 at Canaccord
Canaccord analyst Arlinda Lee lowered her price target on Ultragenyx to $108 from $120 due to an expected increase in R&D spending after the company reported pipeline progress on four clinical candidates and said it expects to file for U.S. KRN23 pediatric approval earlier than expected in the second half of 2017. Lee reiterated her Buy rating on Ultragenyx shares as she expects regulatory approvals in 2017, while also citing its attractive pipeline.
11/14/16
SBSH
11/14/16
DOWNGRADE
Target $64
SBSH
Sell
Ultragenyx downgraded to Sell from Neutral at Citi
Citi analyst Yigal Nochomovitz downgraded Ultragenyx to Sell after removing Ace-ER sales from his model "in the absence of stronger data." The analyst lowered his price target for the shares to $64 from $66.

TODAY'S FREE FLY STORIES

PES

Pioneer Energy

$6.70

0.45 (7.20%)

05:31
12/07/16
12/07
05:31
12/07/16
05:31
Syndicate
Pioneer Energy 10.5M share Spot Secondary priced at $5.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SLM

Sallie Mae

$10.78

0.23 (2.18%)

05:30
12/07/16
12/07
05:30
12/07/16
05:30
Initiation
Sallie Mae initiated  »

Sallie Mae initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIK

Michaels

$23.85

-0.46 (-1.89%)

05:29
12/07/16
12/07
05:29
12/07/16
05:29
Downgrade
Michaels rating change  »

Michaels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$71.97

0.3 (0.42%)

05:28
12/07/16
12/07
05:28
12/07/16
05:28
Downgrade
Kellogg rating change  »

Kellogg downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$17.03

0.03 (0.18%)

05:28
12/07/16
12/07
05:28
12/07/16
05:28
Initiation
Navient initiated  »

Navient initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSK

Verisk Analytics

$83.04

0.13 (0.16%)

05:25
12/07/16
12/07
05:25
12/07/16
05:25
Initiation
Verisk Analytics initiated  »

Verisk Analytics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CMCO

Columbus McKinnon

$27.59

1.07 (4.03%)

05:25
12/07/16
12/07
05:25
12/07/16
05:25
Hot Stocks
Columbus McKinnon to acquire STAHL CraneSystems for about $240M »

Columbus McKinnon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLGX

CoreLogic

$37.89

-0.28 (-0.73%)

05:24
12/07/16
12/07
05:24
12/07/16
05:24
Initiation
CoreLogic initiated  »

CoreLogic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

MGP

MGM Growth

$24.60

-0.18 (-0.73%)

, GLPI

Gaming and Leisure Properties

$30.70

0.24 (0.79%)

05:21
12/07/16
12/07
05:21
12/07/16
05:21
Downgrade
MGM Growth, Gaming and Leisure Properties, Boyd Gaming rating change  »

MGM Growth downgraded to…

MGP

MGM Growth

$24.60

-0.18 (-0.73%)

GLPI

Gaming and Leisure Properties

$30.70

0.24 (0.79%)

BYD

Boyd Gaming

$19.63

0.39 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASX

Advanced Semiconductor

$5.38

0.11 (2.09%)

05:20
12/07/16
12/07
05:20
12/07/16
05:20
Hot Stocks
Advanced Semiconductor reports Nov. revenue up 1.3% to $821M »

Reports November ATM net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIA

Acacia Communications

$70.14

1.08 (1.56%)

05:19
12/07/16
12/07
05:19
12/07/16
05:19
Hot Stocks
Acacia Communications establishes EMEA-APAC headquarters in Limerick, Ireland »

Acacia Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$68.96

-0.01 (-0.01%)

05:18
12/07/16
12/07
05:18
12/07/16
05:18
Hot Stocks
Novartis drug Lucentis receives EU approval in new indication »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$63.85

1.76 (2.83%)

05:18
12/07/16
12/07
05:18
12/07/16
05:18
Recommendations
Western Digital analyst commentary  »

Western Digital price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$12.56

0.12 (0.96%)

05:16
12/07/16
12/07
05:16
12/07/16
05:16
Hot Stocks
Ford reports Nov. China sales up 17% to 124,113 vehicles »

Ford and its joint…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

MU

Micron

$19.06

0.45 (2.42%)

05:15
12/07/16
12/07
05:15
12/07/16
05:15
Initiation
Micron initiated  »

Micron initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 21

    Dec

ESGR

Enstar Group

$194.15

0.5 (0.26%)

05:12
12/07/16
12/07
05:12
12/07/16
05:12
Hot Stocks
Enstar Group announces reinsurance of QBE Legacy U.S. business »

Enstar Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRUE

TrueCar

$12.44

0.02 (0.16%)

05:10
12/07/16
12/07
05:10
12/07/16
05:10
Recommendations
TrueCar analyst commentary  »

TrueCar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWI

Titan International

$11.68

0.08 (0.69%)

05:10
12/07/16
12/07
05:10
12/07/16
05:10
Hot Stocks
Titan International appoints interim CFO James Froisland to CFO »

The board of Titan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$93.86

1.11 (1.20%)

, HPE

HP Enterprise

$23.96

-0.25 (-1.03%)

05:08
12/07/16
12/07
05:08
12/07/16
05:08
Recommendations
Arista Networks, HP Enterprise analyst commentary  »

Arista Networks price…

ANET

Arista Networks

$93.86

1.11 (1.20%)

HPE

HP Enterprise

$23.96

-0.25 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

DPSGY

Deutsche Post

$31.62

0.015 (0.05%)

05:03
12/07/16
12/07
05:03
12/07/16
05:03
Upgrade
Deutsche Post rating change  »

Deutsche Post upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLLLY

Delta Lloyd

05:03
12/07/16
12/07
05:03
12/07/16
05:03
Upgrade
Delta Lloyd rating change  »

Delta Lloyd upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSREY

Swiss Re

$23.68

0.195 (0.83%)

05:02
12/07/16
12/07
05:02
12/07/16
05:02
Upgrade
Swiss Re rating change  »

Swiss Re upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZURVY

Zurich Insurance

$26.82

0.365 (1.38%)

05:01
12/07/16
12/07
05:01
12/07/16
05:01
Upgrade
Zurich Insurance rating change  »

Zurich Insurance upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AV

Aviva

$11.86

0.36 (3.13%)

05:00
12/07/16
12/07
05:00
12/07/16
05:00
Upgrade
Aviva rating change  »

Aviva upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$38.34

-0.4 (-1.03%)

04:58
12/07/16
12/07
04:58
12/07/16
04:58
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.